CSL – the star performer in manufacturing

Analysis by Peter Roberts Blood and vaccine product company CSL (ASX: CSL) is living proof that manufacturing can not only prosper from an Australian base, but can find support among Australian investors. The company along with medical device makers, Cochlear and ResMed, stands alone in an investment landscape that otherwise is patchy in its support…

Impression Healthcare wins right to sell medical cannabis products

Local manufacturer Impression Healthcare (ASX: IHL) has received the required licenses to allow it to make and sell medical cannabis products in Australia. The company announced today it had received licenses from the Victorian Department of Health to sell products containing four scheduled cannabinoid substances. The approvals cover cannabis, cannabidiol (CBD), tetrahydrocannabinols (THC) and dronabinol.…

Brain scanner manufacturer EMvision lists on ASX

EMvision Medical Devices (ASX: EMV) has successfully listed on the Australian stock exchange following an over-subscribed IPO that raised $6 million. The company, which makes a new type of non-invasive brain scanner to detect stroke, will use the funds to continue human trials and refine its prototypes intended to be carried in ambulances by first…

Ansell responds to allegations of exploitation by suppliers

Australia’s multi-national maker of rubber surgical and industrial gloves, Ansell (ASX: ANN), has been implicated in sales of rubber gloves made by Malaysian factories that allegedly exploit their labour forces. The UK controversy, involving supply to the NHS health service, alleges forced labour, forced overtime, debt bondage, withheld wages and passport confiscation at suppliers Top…

Bionic eye breakthrough – next come industry opportunities?

Comment by Peter Roberts. Medical researchers and a private company developing a surgical implant to restore some sight to the blind have passed an important milestone, with the technology’s future commercialisation now in play. Bionic Vision, a consortium of Melbourne research groups, and privately funded Bionic Vision Technologies, have successfully restored ‘a sense of vision’…

Cochlear expands into ResMed’s field of sleep apnea.

Hearing implant maker Cochlear (ASX:COH) has expanded beyond its hearing speciality into the field of sleep, an area now dominated by fellow Australian manufacturer ResMed. Cochlear invested $21 million in a capital raising by Nyxoah S.A., a Belgian medical device company commercialising a nerve stimulation implant for the treatment of Obstructive Sleep Apnea. Jan Janssen,…